Keywords: app, reports, start, ph, ii, trial, abraxane/herceptin

APP reports start of Ph II trial of Abraxane/Herceptin

Article | 18 April 2005

Print This

American Pharmaceutical Partners has announced the start of enrollment in a 70-patient Phase II study of its anticancer agent Abraxane ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in